CN103566077B - A kind of medicament for the treatment of hysteromyoma - Google Patents

A kind of medicament for the treatment of hysteromyoma Download PDF

Info

Publication number
CN103566077B
CN103566077B CN201310524790.9A CN201310524790A CN103566077B CN 103566077 B CN103566077 B CN 103566077B CN 201310524790 A CN201310524790 A CN 201310524790A CN 103566077 B CN103566077 B CN 103566077B
Authority
CN
China
Prior art keywords
radix
herba
medicament
hysteromyoma
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310524790.9A
Other languages
Chinese (zh)
Other versions
CN103566077A (en
Inventor
张志平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZHANG ZHIPING
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310524790.9A priority Critical patent/CN103566077B/en
Publication of CN103566077A publication Critical patent/CN103566077A/en
Application granted granted Critical
Publication of CN103566077B publication Critical patent/CN103566077B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of medicament for the treatment of hysteromyoma, it is made up of following bulk drugs: rock Rhizoma Zingiberis Recens seven, Caulis Seu Folium Callicarpae Kwangtungensis, Radix Crotonis Crassifolii, Herba tiarellae polyphyllae, Herba Moslae Cavaleriei, Radix et Rhizoma Iridis Sanguineae, Radix grewiae bilobae, Radix seu Folium Cinnamomi angustifolii, Rauvolfia verticillata, Herba Zornia Diphyllae, Radix Pouzolziae Sanguineae and Herba Gynurae bicoloris.The reasonable recipe of medicament of the present invention, clear curative effect, can treat hysteromyoma effectively.

Description

A kind of medicament for the treatment of hysteromyoma
Technical field
The present invention relates to oncology nursing field, specifically, relate to a kind of medicament for the treatment of hysteromyoma.
Background technology
Hysteromyoma, also known as leiomyoma of uterus, is the modal a kind of benign tumors of female sex organs.How asymptomatic, minority shows as vaginal hemorrhage, and abdominal part touches swollen thing and pressure symptom etc.As can pain be caused when there is torsion of pedicle or other situations, common with multiple myomata.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of hysteromyoma.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of hysteromyoma, it is made up by weight of following bulk drugs:
Preferably, it is made up by weight of following bulk drugs:
Preferably, described medicament of the present invention is tablet, dispersible tablet, capsule or decoction.
With reference to " Chinese medicine voluminous dictionary " second edition, being described as follows of the crude drug used in the present invention:
The reasonable recipe of medicament of the present invention, clear curative effect, can treat hysteromyoma effectively.
Detailed description of the invention
Below by way of the description of detailed description of the invention, the invention will be further described, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, various amendment or improvement can be made, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get rock Rhizoma Zingiberis Recens 7 15 grams, Caulis Seu Folium Callicarpae Kwangtungensis 30 grams, Radix Crotonis Crassifolii 15 grams, Herba tiarellae polyphyllae 10 grams, Herba Moslae Cavaleriei 15 grams, Radix et Rhizoma Iridis Sanguineae 45 grams, Radix grewiae bilobae 30 grams, Radix seu Folium Cinnamomi angustifolii 10 grams, Rauvolfia verticillata 10 grams, Herba Zornia Diphyllae 15 grams, Radix Pouzolziae Sanguineae 50 grams and Herba Gynurae bicoloris 30 grams, be placed in 5000 ml waters, reflux 2 hours at 80 DEG C, filter, filtrate is decoction of the present invention.
Experimental example
30 routine patients are Gynecologic Outpatients, minimum 24 years old of age, maximum 48 years old.Except minority case, all have incessant dripping of menstrual blood, companion's lumbago and lower abdomen pendant pain, menstrual cycle shortens, and menostaxis is many through blood volume; Also has hypomenorrhea, amenorrhea, fetal abortion, abortion, infertility.30 routine patients all look into uterus " B ultrasonic " prompting: body of uterus obviously increases, and sees tumor body.The course of disease is the longest 3 years, the shortest 6 months.
The decoction choosing preparation in embodiment 1 is treated.Every day 2 times, each 50 milliliters.Within 14 days, be 1 course for the treatment of, treat six courses for the treatment of.Treatments period is stopped using other drug.
Treatment standard
Recovery from illness: patients symptomatic disappears, menstrual cycle rule is few through blood volume, and abdomen pendant pain, lumbago disappear, and look into: uterus B ultrasonic is pointed out: uterus size is normal range, no abnormality seen; Take a turn for the better: patient main suit's menstrual cycle rule obviously reduces through blood volume, without few abdomen pendant pain, lumbago sense, looks into: uterus B ultrasonic is pointed out: body of uterus obviously reduces, tumor body range shorter; Do not heal: patients symptomatic has no improvement, look into: uterus B ultrasonic is pointed out: unchanged without significant change, body of uterus size, tumor body has no and reduces; Consider to adopt other method or operative treatment according to conditions of patients.
Therapeutic outcome
After the treatment, 18 examples meet the standard of recovery from illness to described 30 routine patients, and 12 examples meet the standard of improvement.
Untoward reaction and toxic and side effects supervision: by detect patient blood pressure, pulse, whether there is Nausea and vomiting, dizzy clinical symptoms judges untoward reaction.Finding that the systolic pressure of 30 routine patients is at 90-140mmHg, diastolic pressure 60-90mmHg, pulse is 60-100 time/per minute, all within normal range, and there is not Nausea and vomiting, dizzy clinical symptoms in blood pressure and pulse.This illustrates that pharmaceutical composition of the present invention does not have obvious untoward reaction, and then proves that this medicine does not have obvious toxic and side effects for human body.

Claims (2)

1. treat a medicament for hysteromyoma, it is characterized in that, it is made up by weight of following bulk drugs:
2. the medicament for the treatment of hysteromyoma according to claim 1, is characterized in that, it is made up by weight of following bulk drugs:
CN201310524790.9A 2013-10-31 2013-10-31 A kind of medicament for the treatment of hysteromyoma Expired - Fee Related CN103566077B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310524790.9A CN103566077B (en) 2013-10-31 2013-10-31 A kind of medicament for the treatment of hysteromyoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310524790.9A CN103566077B (en) 2013-10-31 2013-10-31 A kind of medicament for the treatment of hysteromyoma

Publications (2)

Publication Number Publication Date
CN103566077A CN103566077A (en) 2014-02-12
CN103566077B true CN103566077B (en) 2016-02-17

Family

ID=50039358

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310524790.9A Expired - Fee Related CN103566077B (en) 2013-10-31 2013-10-31 A kind of medicament for the treatment of hysteromyoma

Country Status (1)

Country Link
CN (1) CN103566077B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1813974A (en) * 2005-11-23 2006-08-09 王浩贵 Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1813974A (en) * 2005-11-23 2006-08-09 王浩贵 Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati

Also Published As

Publication number Publication date
CN103566077A (en) 2014-02-12

Similar Documents

Publication Publication Date Title
CN102488813B (en) Medicine for curing fibroid
CN103705846B (en) The Chinese medicine preparation for the treatment of ovarian cyst
CN104147194B (en) Traditional Chinese medicine composition for treating chronic sinusitis
CN103566077B (en) A kind of medicament for the treatment of hysteromyoma
CN103610932B (en) Medicament for treating urinary calculus
CN103479970A (en) External medicine for treating rheumatic arthralgia
CN102698065B (en) Medicine composition for treating primary dysmenorrhea
CN105233088A (en) Medicine for treating chronic pelvic inflammatory disease
CN104758462B (en) A kind of powder for the treatment of acute cholecystitis
CN104547851B (en) One treats hypertensive medicine
CN103566225B (en) Medicament for treating gynecological postoperative gastrointestinal dysfunction
CN102600408B (en) Medicine for curing hyperplasia of mammary glands
CN101879227B (en) Chinese medicinal composition for treating protrusion of lumbar intervertebral disci and preparation method thereof
CN103585411B (en) A kind of medicament for the treatment of hemorrhoid
CN102488797B (en) Medicinal composition for treating dysmenorrhea
CN102671076B (en) Medicament for treating gout
CN102362897A (en) Use of Hulisan Jiaonang in preparation of medicine for treating scabies
CN105147817B (en) A kind of Chinese materia medica preparation and preparation method thereof for treating ecphyaditis
CN101884701B (en) Medicament for treating herpes zoster
CN104491764A (en) Medicine composition used for treating anus eczema
CN102552808B (en) Medicament for treating vaginal bleeding after abortion
CN102671048B (en) Medicament for treating chronic urinary tract infections
CN105194226A (en) Medicinal composition for preventing and treating gestational hypertension, and application thereof
CN103599503A (en) Medicine for treating critical diseases and preparation method thereof
CN104523798A (en) Traditional Chinese medicine composition for treating chronic liver disease and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Zhang Zhiping

Inventor before: Gao Dongqin

COR Change of bibliographic data
TA01 Transfer of patent application right

Effective date of registration: 20151106

Address after: 272100 Department of oncology, the first people's Hospital of Jining, 6 health Road, Shandong, Jining

Applicant after: Zhang Zhiping

Address before: 272100 people's Hospital of Jining City, Jining City, Shandong Province Health Road No. 6

Applicant before: Gao Dongqin

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160217

Termination date: 20161031

CF01 Termination of patent right due to non-payment of annual fee